Tag: Immune checkpoint inhibitors

Chimeric Antigen Receptor (CAR) T cell therapies have heralded a new era in oncological treatment, yielding transformative outcomes particularly in ...

In the field of cancer research, the complexities of immunology and metabolism present a fascinating but daunting landscape. Recent findings ...

In a breakthrough study that may revolutionize cancer treatment paradigms, researchers at Cincinnati Children’s have uncovered a critical genetic mutation ...

In the relentless battle against cancer, immunotherapy has emerged as a beacon of hope, revolutionizing treatment paradigms with its ingenious ...

Immunotherapy has emerged as a pivotal area of research in the global fight against tuberculosis (TB), a disease that has ...

In a landmark discovery that could alter the course of cancer treatment, researchers at The University of Texas MD Anderson ...

In a groundbreaking phase Ib clinical trial published in BMC Cancer, researchers have unveiled promising results exploring the combination of ...

In a groundbreaking real-world study published in BMC Cancer, researchers have unveiled compelling evidence supporting the survival benefits of combining ...

The Intricacies and Therapeutic Promise of Mismatch Repair-Deficient Cancers In the ever-evolving landscape of cancer biology, one molecular pathway has ...

In recent years, the intricate relationship between DNA repair mechanisms and cancer development has come into sharper focus, spotlighting a ...

A groundbreaking editorial recently published in the latest volume of Oncoscience sheds new light on the complex relationship between immune ...

In the rapidly evolving field of oncology, immune checkpoint inhibitors (ICIs) have revolutionized the treatment landscape for various cancers, offering ...